Key result
CTPA use for suspected PE climbs ~5.5-fold from 2004 to 2016 as V/Q scans drop.
Why the study?
Despite efforts to implement decision rules and reduce unnecessary CTPA testing for suspected PE, it was unclear whether advanced imaging use had diminished over time.
Did the utilization rates of chest CT, CTPA, and V/Q scanning for suspected pulmonary embolism change from 2004 to 2016 among adults enrolled in US health care systems?
Cohort
Yes
Did the utilization rates of chest CT, CTPA, and V/Q scanning for suspected pulmonary embolism change from 2004 to 2016 among adults enrolled in US health care systems?
Despite widespread dissemination of clinical decision rules and national initiatives to curb diagnostic overuse, chest CT and CTPA utilization for suspected pulmonary embolism continued to grow through 2016, albeit at a slower rate in recent years.
Answers are grounded in this paper and cite their sources.
Rising imaging rates despite guidelines signal need for improved stewardship; leaves open effectiveness of decision rules in real-world settings.
Importance: In response to calls to reduce unnecessary diagnostic testing with computed tomographic pulmonary angiography (CTPA) for suspected pulmonary embolism (PE), there have been growing efforts to create and implement decision rules for PE testing. It is unclear if the use of advanced imaging tests for PE has diminished over time. Objective: To assess the use of advanced imaging tests, including chest computed tomography (CT) (ie, all chest CT except for CTPA), CTPA, and ventilation-perfusion (V/Q) scan, for PE from 2004 to 2016. Design, Setting, and Participants: Cohort study of adults by age group (18-64 years and ≥65 years) enrolled in 7 US integrated and mixed-model health care systems. Joinpoint regression analysis was used to identify years with statistically significant changes in imaging rates and to calculate average annual percentage change (growth) from 2004 to 2007, 2008 to 2011, and 2012 to 2016. Analyses were conducted between June 11, 2019, and March 18, 2020. Main Outcomes and Measures: Rates of chest CT, CTPA, and V/Q scan by year and age, as well as annual change in rates over time. Results: Overall, 3.6 to 4.8 million enrollees were included each year of the study, for a total of 52 343 517 person-years of follow-up data. Adults aged 18 to 64 years accounted for 42 223 712 person-years (80.7%) and those 65 years or older accounted for 10 119 805 person-years (19.3%). Female enrollees accounted for 27 712 571 person-years (52.9%). From 2004 and 2016, chest CT use increased by 66.3% (average annual growth, 4.4% per year), CTPA use increased by 450.0% (average annual growth, 16.3% per year), and V/Q scan use decreased by 47.1% (decreasing by 4.9% per year). The use of CTPA increased most rapidly from 2004 to 2006 (44.6% in those aged 18-64 years and 43.9% in those ≥65 years), with ongoing rapid growth from 2006 to 2010 (annual growth, 19.8% in those aged 18-64 years and 18.3% in those ≥65 years) and persistent but slower growth in the most recent years (annual growth, 4.3% in those aged 18-64 years and 3.0% in those ≥65 years from 2010 to 2016). The use of V/Q scanning decreased steadily since 2004. Conclusions and Relevance: From 2004 to 2016, rates of chest CT and CTPA for suspected PE continued to increase among adults but at a slower pace in more contemporary years. Efforts to combat overuse have not been completely successful as reflected by ongoing growth, rather than decline, of chest CT use. Whether the observed imaging use was appropriate or was associated with improved patient outcomes is unknown.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2020) conducted a cohort in Suspected pulmonary embolism. Computed tomographic pulmonary angiography (CTPA), chest CT, and ventilation-perfusion (V/Q) scan utilization over calendar time (2004-2016) vs. Baseline year (2004) and prior time periods (2004-2007, 2008-2011, 2012-2016) was evaluated on Rates of chest CT, CTPA, and V/Q scan per 1000 person-years and annual percentage change in rates from 2004 to 2016 (450.0% increase in CTPA use (average annual growth 16.3% per year)). CTPA use for suspected pulmonary embolism increased by 450.0% and chest CT increased by 66.3% from 2004 to 2016, while V/Q scan use decreased by 47.1%.
Synapse has enriched 10 related papers. Consider them for comparative context: